BACKGROUND: Research on evaluating the efficacy of non-cultured epidermal cell suspension (NCECS) combined with excimer lamps for the treatment of vitiligo is currently unavailable. This research aims to evaluate the efficacy of this combination in treating vitiligo. METHODS: A prospective, controlled study was conducted from November 2021 to January 2024. Patients with stable vitiligo were randomly assigned into groups 1 (NCECS combined with excimer lamps) or 2 (NCECS alone). All patients were followed up 18 months after the procedure. Treatment effectiveness and adverse events were recorded. RESULTS: Sixty patients were randomly assigned to groups 1 (30 patients) and 2 (30 patients). A total of 33.3% of patients in group 1 achieved 100% repigmentation, significantly higher than the 6.7% in group 2 (p-value = 0.021). Meanwhile, 63.3% of patients in group 1 achieved ≥ 90% repigmentation, higher than the 50% in group 2 but not statistically significant (p-value = 0.435). The mean time to initial repigmentation in group 1 (2.35 ± 0.575 weeks) was significantly shorter than in group 2 (2.72 ± 0.665 weeks) (p-value = 0.003). Both groups demonstrated a similar rate of good color match, but group 1 exhibited a lower incidence of the halo phenomenon. A total of 23.3% of patients in group 1 experienced mild erythema, which spontaneously resolved in a few days. CONCLUSIONS: The combination of NCECS and excimer lamps can substantially stimulate the onset of repigmentation and enhance 100% repigmentation compared to NCECS monotherapy. Excimer lamps may reduce the incidence of the halo phenomenon.